![Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases | Business Wire Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases | Business Wire](https://mms.businesswire.com/media/20191118005269/en/757140/5/4124560_NN_m_2c_RGB_large.jpg)
Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases | Business Wire
![Novo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - Nordic Life Science – the leading Nordic life science news service Novo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - Nordic Life Science – the leading Nordic life science news service](https://nordiclifescience.org/wp-content/public_html/2021/12/original-1-e1639388222261.jpeg)
Novo Nordiskt to invest more than 17 billion DKK in manufacturing facilities - Nordic Life Science – the leading Nordic life science news service
![Novo Nordisk Updates 340B Contract Pharmacy Policy, Will Allow Claims Submission to 340B ESP – 340B Report Novo Nordisk Updates 340B Contract Pharmacy Policy, Will Allow Claims Submission to 340B ESP – 340B Report](https://340breport.com/wp-content/uploads/2022/12/Twitter-Post2-940x510.jpg)
Novo Nordisk Updates 340B Contract Pharmacy Policy, Will Allow Claims Submission to 340B ESP – 340B Report
![Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools – GeekWire Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools – GeekWire](https://cdn.geekwire.com/wp-content/uploads/2018/10/NovoNordiskImage.png)